Search Results - "Blee, Shannon M."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Dissemination of validated health literacy videos: A tailored approach by Blee, Shannon M., Facdol, Jamil, Dixon, Margie D., Master, Viraj, Switchenko, Jeffrey M., Pentz, Rebecca D.

    Published in Cancer medicine (Malden, MA) (01-04-2022)
    “…Background Previously, we showed that chemotherapy terminology is difficult for patients to understand. Therefore, we developed short videos explaining key…”
    Get full text
    Journal Article
  2. 2

    Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting by Abernethy, Eli R., Campbell, Gavin P., Hianik, Rachel S., Thomson, Mary Catherine, Blee, Shannon M., Sibold, Hannah C., Dixon, Margie D., Switchenko, Jeffrey M., Pentz, Rebecca D.

    Published in Cancer (15-10-2021)
    “…Background Therapeutic misconception (TM) refers to research subjects' failure to distinguish the goals of clinical research from standard personal care. TM…”
    Get full text
    Journal Article
  3. 3

    Physician Communication and Patient Understanding of Molecular Testing Terminology by Blee, Shannon M., Shah, Rachel Pocock, Pinheiro, Ana P.M., Switchenko, Jeffrey, Dixon, Margie, Owonikoko, Taofeek K., Hill, Charles E., Szabo, Stephen M., Pentz, Rebecca D.

    Published in The oncologist (Dayton, Ohio) (01-11-2021)
    “…Background The use of molecular testing in oncology is rapidly expanding. The aim of this study was to determine how oncologists describe molecular testing and…”
    Get full text
    Journal Article
  4. 4

    Accounting for the high enrollment of African Americans in Winship Cancer Institute’s myeloma clinical trials by McClary, Tekiah, Blee, Shannon M., Avinger, Anna, Switchenko, Jeffrey M., Dixon, Margie D., Pentz, Rebecca D.

    Published in Journal of clinical oncology (01-06-2022)
    “…12016 Background: Multiple myeloma (MM) is twice as common in African Americans (AA) as in Whites, yet AA make up only 5% of multiple myeloma (MM) clinical…”
    Get full text
    Journal Article
  5. 5

    Dissemination of validated health literacy videos: A tailored approach by Blee, Shannon M., Dixon, Margie D., Master, Viraj A., Pentz, Rebecca D.

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e18505 Background: Previously, we showed that chemotherapy and precision medicine terminology are remarkably difficult for patients to…”
    Get full text
    Journal Article
  6. 6

    Improving first-in-human and window-of-opportunity informed consent forms through participant feedback by Avinger, Anna, Sibold, Hannah Claire, Campbell, Gavin Paul, Abernethy, Eli Rowe, Bourgeois, John, McClary, Tekiah, Blee, Shannon M., Dixon, Margie D., Harvey, R. Donald, Pentz, Rebecca D.

    Published in Journal of clinical oncology (01-06-2022)
    “…1562 Background: Although patient advocates have created templates for standard consent forms, assessing patient preferences for First in Human (FIH) and…”
    Get full text
    Journal Article
  7. 7

    Misunderstanding immunotherapy: An analysis of provider-patient conversations by Blee, Shannon M., Rosenberg, Bari, Switchenko, Jeffrey M., Hianik, Rachel, Thomson, Mary Catherine, Dixon, Margie D., Bilen, Mehmet Asim, Pentz, Rebecca D.

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e18638 Background: Immunotherapy terminology is often complex and can be difficult for patients to understand, threatening both informed consent…”
    Get full text
    Journal Article